title: Real-life long-term omalizumab therapy in children with severe allergic asthma.
authors.affiliation: Unité de pneumologie et allergologie pédiatriques, pôle enfant, clinique de pédiatrie Jeanne de Flandre, CHRU de Lille, Université Nord de France, Lille, France antoine.deschildre@chru-lille.fr.
authors.forename: Antoine
authors.initials: A
authors.lastname: Deschildre
authors.affiliation: Pediatric respiratory disease and allergy unit, University Charles Nicolle Hospital, EA3830 GHRV, Rouen University, Rouen, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Marguet
authors.affiliation: Département de biostatistiques, CHRU de Lille, Université Nord de France, Lille, France.
authors.forename: Carole
authors.initials: C
authors.lastname: Langlois
authors.affiliation: Pédiatrie, Pôle Couple Enfants, CHU de Grenoble, INSERM U823, Institut Albert Bonniot, Université Joseph Fourier, Grenoble, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Pin
authors.affiliation: Allergologie - Pneumologie, Hôpital des Enfants, CHU Purpan Toulouse, Toulouse, France.
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Rittié
authors.affiliation: Service de pédiatrie 1, Hôpital d'enfants de Brabois, CHU Nancy, Vandoeuvre-Lés-Nancy, France.
authors.forename: Jocelyne
authors.initials: J
authors.lastname: Derelle
authors.affiliation: Service de pneumologie et d'allergologie pédiatriques, hôpital Necker-Enfants-Malades, Paris, France.
authors.forename: Rola
authors.initials: R
authors.lastname: Abou Taam
authors.affiliation: CHU de Bordeaux, Département de Pédiatrie, Centre d'Investigation Clinique (CIC 0005), Bordeaux, France.
authors.forename: Michael
authors.initials: M
authors.lastname: Fayon
authors.affiliation: CHU de Caen, Dept of Pediatrics, Research unit EA 4655 U2RM, Caen, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Brouard
authors.affiliation: Unité de pneumologie et médecine infantile, CNRS, URMITE 6236, CHU Timone-Enfants, Aix-Marseille Université, Marseille, France.
authors.forename: Jean Christophe
authors.initials: JC
authors.lastname: Dubus
authors.affiliation: Service de Pédiatrie, CH de Saint-Nazaire, Saint-Nazaire, France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Siret
authors.affiliation: Pôle médico-chirurgical de Pédiatrie, CHU de Hautepierre, Strasbourg, France.
authors.forename: Laurence
authors.initials: L
authors.lastname: Weiss
authors.affiliation: Service de pediatrie, CH Roubaix, Roubaix, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Pouessel
authors.affiliation: CIC-9301-Inserm-CHU (Centre d'Investigation Clinique de Lille), CHRU de Lille and U995 Inserm, and Université Nord de France, Lille, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Beghin
authors.affiliation: Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau, Paris, France INSERM, UMR_S 1136, Sorbonne Universités, UPMC Université Paris 06, Paris, France Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
authors.forename: Jocelyne
authors.initials: J
authors.lastname: Just
mesh_terms: D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D002648:Child; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D008134:Long-Term Care; D008297:Male; D000069444:Omalizumab / Q000627:therapeutic use*; D012008:Recurrence; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab